MRCHF(MRCHF)
MRCHF
No analyst ratings available
No analyst price targets available for MRCHF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $255.81B | $267.96B | $279.69B |
| Low | $254.02B | $266.07B | $277.72B |
| High | $257.39B | $270.84B | $282.07B |
| EBITDA Avg | $32.28B | $33.82B | $35.30B |
| Low | $32.06B | $33.58B | $35.05B |
| High | $32.48B | $34.18B | $35.60B |
| EBIT Avg | $12.31B | $12.89B | $13.46B |
| Low | $12.22B | $12.80B | $13.36B |
| High | $12.38B | $13.03B | $13.57B |
| Net Income Avg | $5.77B | $8.93B | $11.51B |
| Low | $5.71B | $8.85B | $11.41B |
| High | $5.83B | $9.03B | $11.64B |
| EPS Avg | $102.58 | $158.91 | $204.85 |
| Low | $101.65 | $157.46 | $202.98 |
| High | $103.72 | $160.67 | $207.12 |
| Analysts (Rev / EPS) | 3 / 1 | 4 / 1 | 3 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $64.71B | $65.37B | $61.01B |
| Low | $64.71B | $65.37B | $61.01B |
| High | $64.71B | $65.37B | $61.01B |
| EBITDA Avg | $8.17B | $8.25B | $7.70B |
| Low | $8.17B | $8.25B | $7.70B |
| High | $8.17B | $8.25B | $7.70B |
| EBIT Avg | $3.11B | $3.15B | $2.94B |
| Low | $3.11B | $3.15B | $2.94B |
| High | $3.11B | $3.15B | $2.94B |
| Net Income Avg | $1.41B | $1.41B | $1.21B |
| Low | $1.41B | $1.41B | $1.21B |
| High | $1.41B | $1.41B | $1.21B |
| EPS Avg | $25.48 | $25.48 | $21.84 |
| Low | $25.48 | $25.48 | $21.84 |
| High | $25.48 | $25.48 | $21.84 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 |